Home / Life Sciences

Legal News

MHRA and NICE announce joint regulatory reforms to speed up medicine approvals

Copyright © 2025 LexisNexis

Published on: 18 March 2025

Published by LNB News

LNB News 18/03/2025

Document Information

Issue Date: 18 March 2025

Published Date: 18 March 2025

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) outlined new regulatory processes on 17 March 2025 as part of wider government reforms. From July 2025, MHRA will permit point-of-care manufacturing of personalised medicines, while NICE aims to complete 60% of Technology Appraisals within 240 working days by 2025/26. The regulators will launch an integrated scientific advice service and implement concurrent marketing authorisation and technology appraisal processes to reduce approval times for new medicines.

Popular documents

Micklefield clauses

Micklefield clausesWhat is a Micklefield clause?It is common for employee share plans to provide that, on termination of employment (or when an employee is given or receives notice of termination of employment), subsisting share awards will be forfeited and subsisting share options will lapse.It is

Financial clean break orders in family proceedings

Financial clean break orders in family proceedingsDuty of the court to consider a clean breakAlthough there is no presumption in favour of there being a financial clean break between parties on divorce, the court is under a duty to consider whether it would be appropriate to exercise its powers so

Contributory negligence in personal injury claims

Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a

Where are misrepresentations made? Jurisdictional traps for the unwary (Bellmare Holdings Ltd v Wells)

Dispute Resolution analysis: The High Court has provided concise guidance as to how misrepresentation should be analysed when considering jurisdictional gateways. Under Article 5(3) of the Lugano Convention, in negligent misstatement cases, the place of the event giving rise to damage is normally